BNY Mellon Large Cap Securities Fund, Inc.
SCHEDULE OF INVESTMENTS
March 31, 2026 (Unaudited)
 
Description
 
 
 
Shares
Value ($)
Equity Securities - Common Stocks — 99.6%
Banks — 6.3%
Bank of America Corp.
564,607
27,524,591
Fifth Third Bancorp
348,889
16,209,383
First Horizon Corp.
1,634,309
37,196,873
JPMorgan Chase & Co.
187,760
55,231,482
 
136,162,329
Capital Goods — 13.5%
AMETEK, Inc.
189,207
40,558,412
Axon Enterprise, Inc.(a)
45,087
19,147,998
Carrier Global Corp.
338,857
19,081,038
Dover Corp.
100,704
20,991,749
GE Vernova, Inc.
53,402
46,614,606
Howmet Aerospace, Inc.
174,187
40,143,136
Hubbell, Inc.
79,730
39,126,700
Ingersoll Rand, Inc.
468,544
37,539,745
Trane Technologies PLC
63,428
26,432,985
 
289,636,369
Consumer Discretionary Distribution & Retail — 7.9%
Amazon.com, Inc.(a)
524,692
109,277,603
Chewy, Inc., Cl. A(a)
890,969
24,056,163
The TJX Companies, Inc.
229,264
36,613,461
 
169,947,227
Consumer Staples Distribution & Retail — 2.7%
Walmart, Inc.
459,523
57,109,519
Energy — 3.3%
Diamondback Energy, Inc.
98,552
19,492,600
EQT Corp.
442,615
28,168,019
Phillips 66
127,982
23,315,761
 
70,976,380
Financial Services — 5.9%
CME Group, Inc.
101,260
29,907,141
Mastercard, Inc., Cl. A
83,999
41,970,940
The Goldman Sachs Group, Inc.
65,728
55,605,231
 
127,483,312
Health Care Equipment & Services — 4.6%
Alcon AG
229,829
17,317,615
Boston Scientific Corp.(a)
210,134
13,185,909
Edwards Lifesciences Corp.(a)
235,612
18,867,809
IDEXX Laboratories, Inc.(a)
37,134
20,865,223
UnitedHealth Group, Inc.
106,452
28,804,847
 
99,041,403
Household & Personal Products — .9%
The Estee Lauder Companies, Inc., Cl. A
265,470
19,052,782
Insurance — 2.5%
Aon PLC, Cl. A
78,230
25,251,079
Assurant, Inc.
130,061
28,328,587
 
53,579,666
Materials — 1.0%
International Paper Co.
598,316
21,359,881
3
SCHEDULE OF INVESTMENTS (Unaudited) (continued)
Description
 
 
 
Shares
Value ($)
Equity Securities - Common Stocks — 99.6% (continued)
Media & Entertainment — 10.3%
Alphabet, Inc., Cl. C
452,463
129,793,536
Meta Platforms, Inc., Cl. A
120,618
69,009,176
Netflix, Inc.(a)
230,045
22,118,827
 
220,921,539
Pharmaceuticals, Biotechnology & Life Sciences — 6.1%
Gilead Sciences, Inc.
252,456
35,184,793
Insmed, Inc.(a)
116,368
19,028,495
Johnson & Johnson
204,960
50,100,422
Thermo Fisher Scientific, Inc.
56,845
27,941,023
 
132,254,733
Semiconductors & Semiconductor Equipment — 15.4%
Micron Technology, Inc.
123,776
41,816,484
NVIDIA Corp.
1,239,838
216,227,747
Taiwan Semiconductor Manufacturing Co. Ltd., ADR
95,659
32,327,959
Texas Instruments, Inc.
207,744
40,331,420
 
330,703,610
Software & Services — 10.6%
CrowdStrike Holdings, Inc., Cl. A(a)
51,551
20,126,026
Intuit, Inc.
51,167
22,123,587
Microsoft Corp.
346,714
128,343,121
ServiceNow, Inc.(a)
148,643
15,540,626
Shopify, Inc., Cl. A(a)
174,741
20,727,777
Synopsys, Inc.(a)
53,120
21,061,018
 
227,922,155
Technology Hardware & Equipment — 6.0%
Apple, Inc.
510,795
129,634,663
Utilities — 2.6%
Constellation Energy Corp.
104,230
29,106,227
Dominion Energy, Inc.
418,573
25,876,183
 
54,982,410
Total Equity Securities - Common Stocks
(cost $1,150,799,902)
2,140,767,978
 
 
 
1-Day
Yield (%)
 
 
 
Investment Companies — .6%
Registered Investment Companies — .6%
Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional
Shares(b)
(cost $12,066,446)
3.72
12,066,446
12,066,446
Total Investments (cost $1,162,866,348)
 
    100.2%
2,152,834,424
Liabilities, Less Cash and Receivables
 
      (.2%)
   (3,877,948)
Net Assets
    100.0%
2,148,956,476
 
ADR—American Depositary Receipt
 
(a)
Non-income producing security.
(b)
Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company’s
prospectus.
See notes to schedule of investments.
4
Schedule of Investments
BNY Mellon Large Cap Securities Fund, Inc.
March 31, 2026 (Unaudited)
The following is a summary of the inputs used as of March 31, 2026 in valuing the fund’s investments: 
 
Level 1 -
Unadjusted
Quoted Prices
Level 2- Other
Significant
Observable Inputs
Level 3-
Significant
Unobservable
Inputs
Total
Assets ($)
Investments in Securities:†
Equity Securities - Common Stocks
2,140,767,978
—
—
2,140,767,978
Investment Companies
12,066,446
—
—
12,066,446
 
2,152,834,424
—
—
2,152,834,424
 
†
See Schedule of Investments for additional detailed categorizations, if any.
5
The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.
The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.
Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:
Level 1—unadjusted quoted prices in active markets for identical investments.
Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).
Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows:
Equity investments generally are valued at the last sale price on the day of valuation on the securities exchange or national securities market on which such securities primarily are traded. Securities listed on Nasdaq markets generally will be valued at the official closing price. If there are no transactions in a security, or no official closing prices for a Nasdaq market-listed security on that day, the security will be valued at the average of the most recent bid and asked prices. Bid price is used when no asked price is available. Open short positions for which there is no sale price on a given day are valued at the lowest asked price. Investments in other open-end investment companies are valued at their reported net asset values (“NAVs”) each day. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.
Fair value of foreign equity securities may be determined with the assistance of a pricing service using correlations between the movement of prices of foreign securities and indexes of domestic securities and other appropriate indicators, such as closing market prices of relevant ADRs and futures contracts. The valuation of a security based on this fair value process may differ from the security’s most recent closing price and from the prices used by other mutual funds to calculate their NAVs. Foreign securities held by a fund may trade on days when the fund does not calculate its NAV and thus may affect the fund’s NAV on days when investors will not be able to purchase or sell (redeem) fund shares. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.
Restricted securities, as well as securities or other assets for which recent market quotations or official closing prices are not readily available or are determined not to reflect accurately fair value (such as when the value of a security has been materially affected by events occurring after the close of the exchange or market on which the security is principally traded, but before the fund calculates its NAV), or which are not valued by the Service, are valued at fair value as determined in good faith based on procedures approved by the fund’s Board of Directors (the “Board”). Fair value of investments is determined by the Adviser, as the fund’s valuation designee pursuant to Rule 2a-5 under the Act, using such information as it deems appropriate under the circumstances. The factors that may be considered when fair valuing a security include fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. Using fair value to price investments may result in a value that is different from a security’s most recent closing
6
price and from the prices used by other mutual funds to calculate their NAVs. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.
At March 31, 2026, accumulated net unrealized appreciation on investments was $989,968,076, consisting of $1,076,507,364 gross unrealized appreciation and $86,539,288 gross unrealized depreciation.
At March 31, 2026, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Schedule of Investments).
Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.
7